Phase I Interim Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) Monotherapy for Relapsed/Refractory (R/R) Multiple Myeloma (MM)
暂无分享,去创建一个
M. Amiot | R. Vij | Shaji K. Kumar | P. Moreau | J. Leverson | J. Kaufman | C. Touzeau | J. Ross | T. Facon | S. Enschede | R. Humerickhouse | S. Agarwal | M. Dunbar | J. Mikhael | Ming Zhu | Stefanie Alzate | Lura Morris